These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological therapy for glaucoma: a review. Hoyng PF; van Beek LM Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828 [TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure changes in the contralateral eye after topical treatment: does an "ophthalmotonic consensual reaction" exist? Newman H; Kurtz S; David R Isr Med Assoc J; 2010 Sep; 12(9):568-71. PubMed ID: 21287803 [TBL] [Abstract][Full Text] [Related]
4. [Pleiotropic effects in local drug treatment for glaucoma]. Erb C Klin Monbl Augenheilkd; 2013 Feb; 230(2):141-5. PubMed ID: 23430678 [TBL] [Abstract][Full Text] [Related]
5. Topical therapies for glaucoma: what family physicians need to know. Lewis PR; Phillips TG; Sassani JW Am Fam Physician; 1999 Apr; 59(7):1871-9, 1882. PubMed ID: 10208706 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs. Tanna AP; Rademaker AW; Stewart WC; Feldman RM Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041 [TBL] [Abstract][Full Text] [Related]
7. A history of glaucoma pharmacology. Realini T Optom Vis Sci; 2011 Jan; 88(1):36-8. PubMed ID: 21131876 [TBL] [Abstract][Full Text] [Related]
8. Controversies in Glaucoma: Current Medical Treatment and Drug Development. Bucolo C; Platania CB; Reibaldi M; Bonfiglio V; Longo A; Salomone S; Drago F Curr Pharm Des; 2015; 21(32):4673-81. PubMed ID: 26350532 [TBL] [Abstract][Full Text] [Related]
9. Medical therapy for glaucoma: what to add after a prostaglandin analogs? Tanna AP; Lin AB Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacology aspects of glaucoma]. Alm A; Berggren L Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228 [TBL] [Abstract][Full Text] [Related]
11. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database. Lafuma A; Berdeaux G Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015 [TBL] [Abstract][Full Text] [Related]
12. Adverse events associated with commonly used glaucoma drugs. Vogel R; Strahlman E; Rittenhouse KD Int Ophthalmol Clin; 1999; 39(2):107-24. PubMed ID: 10343928 [No Abstract] [Full Text] [Related]